BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3113406)

  • 21. [Selective depuration of plasma by filtration. An alternative to plasma exchange].
    Puig LL; Mazzara R; Montesinos A; Gelabert A; Castillo R
    Sangre (Barc); 1988 Apr; 33(2):114-20. PubMed ID: 3135612
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
    Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
    J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin resistance during membrane plasmapheresis.
    Yamashita M; Omokawa S; Lucas FV; Takeyama Y; Goldcamp JB; Koo AP; Malchesky PS; Nosè Y
    Prog Clin Biol Res; 1990; 337():367-70. PubMed ID: 2352997
    [No Abstract]   [Full Text] [Related]  

  • 24. Apheresis in hematologic and oncologic disease.
    Cohen RJ
    Hosp Pract (Off Ed); 1983 Oct; 18(10):199-205. PubMed ID: 6413369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmapheresis in hyperviscosity syndrome.
    Avnstorp C; Nielsen H; Drachmann O; Hippe E
    Acta Med Scand; 1985; 217(1):133-7. PubMed ID: 3919530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
    Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
    J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma viscosity changes after sham plasmapheresis.
    Jakoet A; Martell RW; Jacobs P
    Lancet; 1987 Oct; 2(8566):1031-2. PubMed ID: 2889944
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic plasmapheresis in treatment of patients with Waldenström's macroglobulinemia.
    Lawson NS; Nosanchuk JS; Oberman HA; Meyers MC
    Transfusion; 1968; 8(3):174-8. PubMed ID: 4968993
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trials of a cryoglobulin filter.
    Siami GA; Wilkins W; Stone WJ; Koo AP; Zborowski M
    ASAIO J; 1994; 40(3):M658-62. PubMed ID: 8555596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apheresis for lupus erythematosus.
    Wallace DJ
    Lupus; 1999; 8(3):174-80. PubMed ID: 10342709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyperviscosity syndrome, macroglobulinemia].
    Hatta Y; Sawada U
    Nihon Rinsho; 2004 May; 62 Suppl 5():550-3. PubMed ID: 15197982
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of plasmapheresis in immunological kidney diseases. Experience from 1050 completed plasmapheresis treatment sessions].
    Haris A; Arányi J; Braunitzer H; Kálmán E; Merán Z; Soltész M; Polner K
    Orv Hetil; 2011 Jul; 152(28):1110-9. PubMed ID: 21712172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperviscosity in plasma cell dyscrasias.
    Kwaan HC
    Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasma exchange using filtration. Experience at the apropos of 21 patients].
    Simon P; Ang KS; Menault M; Bombail D; Vaucel J; Guezennec M; Boivin M; Bonn F
    Rev Fr Transfus Immunohematol; 1981 Dec; 24(6):671-90. PubMed ID: 6800023
    [No Abstract]   [Full Text] [Related]  

  • 36. Pleural effusion after plasmapheresis in Waldenström's macroglobulinemia.
    Karlinsky J; Seder R; Corral R
    Chest; 1986 Jan; 89(1):146-8. PubMed ID: 3079691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plasmapheresis and plasma exchange. Therapeutic indications and risks].
    Fernández García J
    Rev Clin Esp; 1985 Jun; 177(2):47-52. PubMed ID: 3901155
    [No Abstract]   [Full Text] [Related]  

  • 38. Experience with pre-diluted plasma exchange therapy for hyperviscosity syndrome.
    Igarashi S; Kamikawa Y; Ono S; Maekawa G; Kishigami H; Kawamura K; Oonogi T; Nagano T
    Ther Apher Dial; 2023 Dec; 27(6):1035-1039. PubMed ID: 37605348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma separation using a membrane.
    Hirano R; Namazuda K; Suemitsu J; Harashima T; Hirata N
    Transfus Apher Sci; 2017 Oct; 56(5):649-653. PubMed ID: 28923773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.